Download PDF
Aktuelle Neurologie 2011; 38(06): 315-319
DOI: 10.1055/s-0031-1284408
Aktuelle Therapie
© Georg Thieme Verlag KG Stuttgart · New York

Aktuelle Therapie des Tremors

Current Therapy for Tremor
J. Raethjen
1   Klinik für Neurologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel
› Author Affiliations
Further Information

Publication History

Publication Date:
12 September 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Tremor ist eines der häufigsten neurologischen Symptome, und ist oft behandlungsbedürftig. Es stehen eine Reihe von Medikamenten zur Verfügung, die je nach klinischer Erscheinungsform des Tremors gezielt eingesetzt werden können. Mittlerweile gut etabliert ist die operative stereotaktische Behandlung mittels tiefer Hirnstimulation, die bei fast allen pathologischen Tremorformen deutlich wirksamer ist als die Medikamente. Die Therapieoptionen und die Eskalationsstufen für die häufigsten primär neurologischen Tremorer werden dargestellt.

Abstract

Tremor is one of the most common symptoms in clinical neurology and often needs treatment. Numerous drugs have antitremor effects and should be chosen according to the clinical appearance of the tremor syndrome. Deep brain stimulation after stereotactic electrode placement has meanwhile become a well established therapeutic option the effects of which are by far stronger than those of medical treatment in almost all pathological tremors. The therapeutic options and practical steps in the treatment of most primary neurological tremors are delineated.

Schlüsselwörter

Tremor - medikamentöse Therapie - Tiefe Hirnstimulation

Keywords

tremor - drug treatment - deep brain stimulation
 

  • Literatur

  • 1 Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol 2005; 4: 866-876
    CrossrefPubMedGoogle Scholar
  • 2 Bain P, Brin M, Deuschl G et al. Criteria for the diagnosis of essential tremor. Neurology 2000; 54 (Suppl. 04) S7
    PubMedGoogle Scholar
  • 3 Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13 (Suppl. 03) 2-23
    CrossrefPubMedGoogle Scholar
  • 4 Koller WC. Long-acting propranolol in essential tremor. Neurology 1985; 35: 108-110
    CrossrefPubMedGoogle Scholar
  • 5 O’Suilleabhain P, Dewey Jr RB. Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov Disord 2002; 17: 382-386
    CrossrefPubMedGoogle Scholar
  • 6 Zesiewicz TA. Low-dose topiramate (topamax) in the treatment of essential tremor. Clin Neuropharmacol 2007; 30: 247-248
    PubMedGoogle Scholar
  • 7 Gironell A, Kulisevsky J, Barbanoj M et al. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 1999; 56: 475-480
    CrossrefPubMedGoogle Scholar
  • 8 Ondo W, Hunter C, Vuong KD et al. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 2000; 15: 678-682
    CrossrefPubMedGoogle Scholar
  • 9 Pahwa R, Lyons K, Hubble JP et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 1998; 13: 465-467
    PubMedGoogle Scholar
  • 10 Elble RJ, Pullman SL, Matsumoto JY et al. Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain 2006; 129: 2660-2666
    CrossrefPubMedGoogle Scholar
  • 11 Deuschl G, Raethjen J, Hellriegel H et al. Treatment of patients with essential tremor. Lancet Neurol 2011; 10: 148-161
    CrossrefPubMedGoogle Scholar
  • 12 Rehncrona S, Johnels B, Widner H et al. Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord 2003; 18: 163-170
    CrossrefPubMedGoogle Scholar
  • 13 Raethjen J, Govindan RB, Kopper F et al. Cortical involvement in the generation of essential tremor. J Neurophysiol 2007; 97: 3219-3228
    CrossrefPubMedGoogle Scholar
  • 14 Schnitzler A, Munks C, Butz M et al. Synchronized brain network associated with essential tremor as revealed by magnetoencephalography. Mov Disord 2009; 24: 1629-1635
    CrossrefPubMedGoogle Scholar
  • 15 Ehrt U, Broich K, Larsen JP et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson′s disease: a cohort study. J Neurol Neurosurg Psychiatry 2010; 81: 160-165
    CrossrefPubMedGoogle Scholar
  • 16 Raethjen J, Pohle S, Govindan RB et al. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response. Exp Neurol 2005; 194: 151-160
    CrossrefPubMedGoogle Scholar
  • 17 Papapetropoulos S, Singer C. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series. Clin Neuropharmacol 2006; 29: 364-367
    CrossrefPubMedGoogle Scholar
  • 18 Rodrigues JP, Edwards DJ, Walters SE et al. Blinded placebo crossover study of gabapentin in primary orthostatic tremor. Mov Disord 2006; 21: 900-905
    CrossrefPubMedGoogle Scholar
  • 19 Espay AJ, Duker AP, Chen R et al. Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations. Mov Disord 2008; 23: 2357-2362
    CrossrefPubMedGoogle Scholar
  • 20 Krauss JK, Weigel R, Blahak C et al. Chronic spinal cord stimulation in medically intractable orthostatic tremor. J Neurol Neurosurg Psychiatry 2006; 77: 1013-1016
    CrossrefPubMedGoogle Scholar